884860-63-3

Usage

Uses

Used in Organic Synthesis:
2-Chlorothiazolo[4,5-c]pyridine is used as a building block in the synthesis of various chemical compounds. Its unique structure allows for the creation of a wide range of molecules with different properties and applications.
Used in Pharmaceutical Research:
In the pharmaceutical industry, 2-Chlorothiazolo[4,5-c]pyridine is utilized for its potential pharmacological activities and therapeutic properties. It is a subject of interest in medicinal chemistry, where researchers explore its ability to interact with biological targets and develop new drugs.
Used in Pesticide and Fungicide Development:
2-Chlorothiazolo[4,5-c]pyridine has been investigated for its potential use in the development of pesticides and fungicides. Its chemical properties make it a promising candidate for controlling pests and fungi in the agricultural industry, contributing to crop protection and yield enhancement.

InChI:InChI=1/C6H3ClN2S/c7-6-9-4-3-8-2-1-5(4)10-6/h1-3H

Upstream product

• 89786-54-9 thiazolo[4,5-c]pyridine-2-ylamine 
• 65128-66-7 thiazolo[4,5-c]pyridine-2(3H)-thione 

Relevant academic research and scientific papers

BICYCLIC HETEROARYL SUBSTITUTED COMPOUNDS

Disclosed are compounds of Formula (I) to (VIII): (I) (II) (III) (IV) (V) (VI) (VII) (VIII); or a stereoisomer, tautomer, pharmaceutically acceptable salt, solvate or prodrug thereof, wherein R3 is a bicyclic heteroaryl group substituted with zero to 3 R3a; and R1, R2, R3a, R4, and n are defined herein. Also disclosed are methods of using such compounds as PAR4 inhibitors, and pharmaceutical compositions comprising such compounds. These compounds are useful in inhibiting or preventing platelet aggregation, and are useful for the treatment of a thromboembolic disorder or the primary prophylaxis of a thromboembolic disorder.

NOVEL HETEROARYL-AMINO DERIVATIVES

Disclosed is a compound of formula (I), wherein R1, R2, L, Rm and Rn are as defined herein. The compound of formula (I) may be used in preventing and/or treating acyl CoA-diacylglycerol acyltransferase 1(DGAT-1) related diseases, such as obesity, coronary disease, hypertension, hyperlipidemia, arteriosclerosis, type II diabetes, stroke, hepatitis C, and the like.

Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amines as modulators of leukotriene A4 hydrolase

Thiazolopyridin-2-yloxy-phenyl and thiazolopyrazin-2-yloxy-phenyl amine compounds are described, which are useful as LTA4 hydrolase (LTA4H) modulators. Such compounds may be used in pharmaceutical compositions and methods for modulation of LTA4H and for the treatment of disease states, disorders, and conditions mediated by LTA4 hydrolase activity.

PREPARATION AND USE OF BIPHENYL-4-YL-CARBONYLAMINO ACID DERIVATIVES FOR THE TREATMENT OF OBESITY

This invention relates to certain biphenyl-4-yl carbonylamino acid compounds, compositions, and methods for treating or preventing obesity and related diseases.